It has previously been observed that TGF-β participates in all phases of liver disease development, including early stages like inflammation, steatosis, and fibrosis to advanced stages, such as cirrhosis and HCC (Dooley and Ten Dijke, 2012). This evidence concerns the gene TGFB1 and hepatocellular carcinoma.